Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...

Chinese scientists have discovered subtle new earlier signs of Parkinson’s in mice, an advance that may help diagnose the ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Arkady Renko now fumbles with his keys at the door as his Parkinson’s disease gradually grows worse. The legendary Russian ...

Parkinson’s Disease Support Group: 2 p.m. meeting at Sanford Health WindSong in Bemidji, open to anyone with Parkinson’s ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

A collaborative study led by Professor Vittoria Raffa at the University of Pisa and Assistant Professor Fabian Raudzus ...